MPX Bioceutical Corporation (CSE:MPX) reports financial results for its fiscal year which ended on March 31 and shared a general business update with investors.

As quoted in the press release:

“We recorded strong topline year-end results, with revenue increasing $16.9 million year over year, to $21.3 million, fueled primarily by the Health for Life medical cannabis dispensaries in Phoenix, Arizona,” said W. Scott Boyes, Chairman, President and CEO of MPX. “We are pleased with the success of our business model in Arizona, where both our Health for Life retail dispensary brand and MPX wholesale brand have rapidly gained traction and proved to be popular among medical cannabis patients.”

Mr. Boyes continued, “Our Arizona assets are all cash flow positive. Our strategy is to continue to invest heavily in replicating this Arizona business model in targeted states across the U.S., to rapidly grow market share and to achieve our goal of becoming one of the largest participants in the burgeoning cannabis sector. During the fiscal year 2018, we made excellent progress laying the foundation for this growth by completing management and production agreements in Maryland and Massachusetts. Furthermore, we also reported our first revenues from Nevada, as sales of our wholesale MPX branded products commenced following our acquisition of GreenMart Nevada.”

Beth Stavola, COO added, “Fiscal year 2018 was a breakthrough year for the Company. As a result of our heavy investment in our long term growth strategy, our operations now span multiple jurisdictions in the U.S. and Canada, and we believe we have the capabilities to continue to execute our aggressive expansion strategy to meet the demands of the evolving medicinal and adult-use cannabis market. As we look to the remainder of 2018, we are focused on growing our footprint in a highly competitive and fast paced industry.”

Click here to read the full press release.

Curaleaf Holdings, Inc. (CSE: CURA OTCQX: CURLF) (“Curaleaf” or the “Company”) a leading international provider of consumer products in cannabis, today announced that it will report its financial and operating results for the first quarter ended March 31, 2021 after market close on May 10, 2021 .

Management will host a conference call and audio webcast that evening at 5:00 p.m. ET consisting of prepared remarks followed by a question and answer session related to the Company’s operational and financial highlights.

Keep reading... Show less

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of two new stores, the Company’s 85 th and 86 th nationwide to commemorate the 50 th anniversary of 420, the holiday recognizing cannabis culture.

The new Florida dispensaries, the Company’s 80 th and 81 st in the state, located in Eustis and Palm Beach Gardens , further demonstrate Trulieve’s goal of ensuring direct, reliable access to medical cannabis across its home state.

Keep reading... Show less

CANBUD Distribution Corp. (CSE:CBDX, FSE:CD0) leverages on timely and methodical execution of its revenue generating plan. It operates a trinitarian enterprise model in the plant-based protein, psychedelic pharmaceutical and non-psychedelic nutraceutical, and hemp cannabinoids (CBD) spaces. (

Keep reading... Show less


Keep reading... Show less

Market entry will address pent-up demand in the Japanese & Philippine markets for TRACE proprietary plant-based mineral formulation and wellness-focused products

Emerging leader in innovative health and wellness beverages and natural products, BevCanna Enterprises Inc. ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announces today that has entered into an exclusive sales agency distribution agreement with Yokohama-based Mirai Marketing Inc. (“Mirai”) to bring Naturo Group’s TRACE proprietary plant-based mineral consumer products to Mirai’s extensive Japanese and Philippine sales and distribution networks.

Keep reading... Show less